Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: Implications for human neurological disease and immunotherapeutics

Journal of Neuroinflammation

Volumn 6, Issue , 2009, Pages 31-

  Hill, Kenneth E ^a   Clawson, Susan A ^a   Rose, John W ^a,b,c   Carlson, Noel G ^a,b,c   Greenlee, John E ^a,b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; FLUORESCEIN; FLUOROCHROME; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL VIABILITY; CEREBELLUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; IMMUNOCYTOTOXICITY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IMMUNOTHERAPY; IN VITRO STUDY; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; PURKINJE CELL; RAT; TARGET CELL; TISSUE CULTURE; TISSUE FIXATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELLS, CULTURED; CEREBELLUM; DAUNORUBICIN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOTHERAPY; IMMUNOTOXINS; NERVOUS SYSTEM DISEASES; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70749100708     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-6-31     Document Type: Article

References (46)

1. Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992, 42:1931-1937.
2. Mathy JP, Baum R, Toh BH. Autoantibody to ribosomes and systemic lupus erythematosus. Clin Exp Immunol 1980, 41:73-80. 1536916, 7002392.
3. Storek J, Kunkel LA. Autoimmune anemia, neutropenia, Eaton-Lambert syndrome, and cerebellar degeneration in a patient with lymphoid hyperplasia. South Med J 1994, 87:263-264. 10.1097/00007611-199402000-00023, 8115896.
4. Shimomura T, Kuno N, Takenaka T, Maeda M, Takahashi K. Purkinje cell antibody in lupus ataxia. Lancet 1993, 342:375-376. 10.1016/0140-6736(93)91524-P, 8101621.
5. Owada K, Uchihara T, Ishida K, Mizusawa H, Watabiki S, Tsuchiya K. Motor weakness and cerebellar ataxia in Sjogren syndrome--identification of antineuronal antibody: a case report. J Neurol Sci 2002, 197:79-84. 10.1016/S0022-510X(02)00034-5, 11997071.
6. Greenlee JE, Brashear HR, Herndon RM. Immunoperoxidase labelling of rat brain sections with sera from patients with paraneoplastic cerebellar degeneration and systemic neoplasia. J Neuropathol Exp Neurol 1988, 47:561-571. 10.1097/00005072-198809000-00007, 3049946.
7. Shams'ili S, Grefkens J, de LB, Bent M, Hooijkaas H, Holt B, Vecht C, Sillevis SP. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003, 126:1409-1418. 10.1093/brain/awg133, 12764061.
8. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008, 7:327-340. 2367117, 18339348, 10.1016/S1474-4422(08)70060-7.
9. Borges LF, Elliott PJ, Gill R, Iversen SD, Iversen LL. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science 1985, 228:346-348. 10.1126/science.2580350, 2580350.
10. Mares V, Borges LF, Sidman RL. Uptake and transport of lectins from the cerebrospinal fluid by cells of the immature mouse brain. Acta Histochem 1984, 74:11-19.
11. Chen S, Su HS. Selective labeling by propidium iodide injected into the lateral cerebral ventricle of the rat. Brain Res 1989, 483:379-383. 10.1016/0006-8993(89)90184-4, 2706528.
12. Fabian RH, Ritchie TC. Intraneuronal IgG in the central nervous system. J Neurol Sci 1986, 73:257-267. 10.1016/0022-510X(86)90150-4, 3522806.
13. Karpiak SE, Mahadik SP. Selective uptake by Purkinje neurons of antibodies to S-100 protein. Exp Neurol 1987, 98:453-457. 10.1016/0014-4886(87)90254-8, 3666088.
14. Graus F, Illa I, Agusta M, Ribalta T, Cruz-Sanchez F, Juarez C. Effect of intraventricular injection of anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J Neurol Sci 1991, 106:82-87. 10.1016/0022-510X(91)90198-G, 1779243.
15. Greenlee JE, Burns JB, Rose JW, Jaeckle KA. Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption. Acta Neuropathol Berl 1995, 89:341-345. 10.1007/BF00309627, 7610765.
16. Borges LF, Busis NA. Intraneuronal accumulation of myeloma proteins. Arch Neurol 1985, 42:690-695.
17. Riedel CJ, Muraszko KM, Youle RJ. Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons. Proc Natl Acad Sci USA 1990, 87:5051-5055. 54259, 2367523, 10.1073/pnas.87.13.5051.
18. Muraszko K, Sung C, Walbridge S, Greenfield L, Dedrick RL, Oldfield EH, Youle RJ. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents. Cancer Res 1993, 53:3752-3757.
19. Davis TL, Wiley RG. Anti-Thy-1 immunotoxin, OX7-saporin, destroys cerebellar Purkinje cells after intraventricular injection in rats. Brain Res 1989, 504:216-222. 10.1016/0006-8993(89)91360-7, 2574621.
20. Pai LH, Bookman MA, Ozols RF, Young RC, Smith JW, Longo DL, Gould B, Frankel A, McClay EF, Howell S. Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol 1991, 9:2095-2103.
21. Niimura M, Kobayashi M, Kojima S. A mouse monoclonal antibody that binds to an alpha-stichocyte of Trichinella spiralis. Parasitol Res 1988, 74:271-276. 10.1007/BF00539577, 3129718.
22. Rasheed ZA, Rubin EH. Topoisomerase-interacting agents . DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology 2008, 437-447. Wolters Kluwer/ Lippincott Williams & Wilkins. Philadelphia, DeVita, VT Jr., Lawrence TS, Rosenberg SA,, 8.
23. Simon S, Roy D, Schindler M. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA 1994, 91:1128-1132. 521467, 8302842, 10.1073/pnas.91.3.1128.
24. Shen WC, Ryser HJ. cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem Biophys Res Commun 1981, 102:1048-1054. 10.1016/0006-291X(81)91644-2, 7306187.
25. Diener E, Diner UE, Sinha A, Xie S, Vergidis R. Specific immunosuppression by immunotoxins containing daunomycin. Science 1986, 231:148-150. 10.1126/science.3484557, 3484557.
26. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993, 90:6591-6595. 46978, 8393571, 10.1073/pnas.90.14.6591.
27. Tauer U, Volk B, Heimrich B. Differentiation of Purkinje cells in cerebellar slice cultures: an immunocytochemical and Golgi EM study. Neuropathol Appl Neurobiol 1996, 22:361-369. 10.1111/j.1365-2990.1996.tb01115.x, 8875471.
28. Nag TC, Wadhwa S. Calbindin immunoreactivity in the developing and adult human cerebellum. J Chem Neuroanat 1999, 17:1-12. 10.1016/S0891-0618(99)00016-2, 10569235.
29. King MA. Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 2000, 243:155-166. 10.1016/S0022-1759(00)00232-5, 10986413.
30. Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 1983, 14:609-613. 10.1002/ana.410140603, 6360029.
31. Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM. Antibody types and IgG subclasses in paraneoplastic neurological syndromes. J Neurol Sci 2001, 184:131-7. 10.1016/S0022-510X(01)00442-7, 11239946.
32. Batini C. Cerebellar localization and colocalization of GABA and calcium binding protein-D28K. Arch Ital Biol 1990, 128:127-149.
33. Mori I, Koshizuka T, Goshima F, Ito H, Koide N, Yoshida T, Yokochi T, Kimura Y, Nishiyama Y. Intercellular trafficking activity of herpes simplex virus US11 gene product in the mouse brain. Brain Res Mol Brain Res 2005, 136:158-163. 10.1016/j.molbrainres.2005.02.004, 15893600.
34. Jensen D, Zhang Z, Flynn FW. Trafficking of tachykinin neurokinin 3 receptor to nuclei of neurons in the paraventricular nucleus of the hypothalamus following osmotic challenge. Neuroscience 2008, 155:308-316. 2597028, 18583062, 10.1016/j.neuroscience.2008.05.024.
35. Tamanini F, Yagita K, Okamura H, Horst GT. Nucleocytoplasmic shuttling of clock proteins. Methods Enzymol 2005, 393:418-435. 10.1016/S0076-6879(05)93020-6, 15817303.
36. Nishi M, Takenaka N, Morita N, Ito T, Ozawa H, Kawata M. Real-time imaging of glucocorticoid receptor dynamics in living neurons and glial cells in comparison with non-neural cells. Eur J Neurosci 1999, 11:1927-1936. 10.1046/j.1460-9568.1999.00616.x, 10336661.
37. Marg A, Meyer T, Vigneron M, Vinkemeier U. Microinjected antibodies interfere with protein nucleocytoplasmic shuttling by distinct molecular mechanisms. Cytometry A 2008, 73A:1128-1140. 10.1002/cyto.a.20635, 18773464.
38. Paine PL, Feldherr CM. Nucleocytoplasmic exchange of macromolecules. Exp Cell Res 1972, 74:81-98. 10.1016/0014-4827(72)90483-1, 4342186.
39. Madsen P, Nielsen S, Celis JE. Monoclonal antibody specific for human nuclear proteins IEF 8Z30 and 8Z31 accumulates in the nucleus a few hours after cytoplasmic microinjection of cells expressing these proteins. J Cell Biol 1986, 103:2083-2089. 2114576, 3782292, 10.1083/jcb.103.6.2083.
40. Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 2008, 105:8772-8777. 2438417, 18550843, 10.1073/pnas.0711355105.
41. Giometto B, Bozza F, Argentiero V, Gallo P, Pagni S, Piccinno MG, Tavolato B. Transferrin receptors in rat central nervous system. An immunocytochemical study. J Neurol Sci 1990, 98:81-90. 10.1016/0022-510X(90)90183-N, 2230832.
42. Morris R. Thy-1 in developing nervous tissue. Dev Neurosci 1985, 7:133-160. 10.1159/000112283, 2866949.
43. McKenzie JL, Fabre JW. Distribution of Thy-1 in human brain: immunofluorescence and absorption analyses with a monoclonal antibody. Brain Res 1981, 230:307-316. 10.1016/0006-8993(81)90409-1, 6119137.
44. FitzGerald DJ, Idziorek T, Batra JK. Antitumor activity of a thioether-linked immunotoxin: OVB3-PE. Bioconjugate Chemistry 1990, 1:264-268. 10.1021/bc00004a006, 2096919.
45. Pai LH, Batra JK, FizGerald DJ, Willingham MC, Pastan I. Antitumor effects of B3-PE and B3-LysPE40 in a nude mouse model of a human breast cancer and the evaluation of B3-PE40 in monkeys. Cancer Res 1992, 52:3189-3193.
46. Willingham MC, FitzGerald DJ, Pastan I. Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian carcinoma inhibits the growth of human ovarian cancer cells in a mouse model. Proc Natl Acad Sci USA 1987, 84:2474-2478. 304674, 3104916, 10.1073/pnas.84.8.2474.